These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 27025093)

  • 21. Reduced telomere length in subjects with dementia and diabetes mellitus type 2 is independent of apolipoprotein E4 genotype.
    Kota LN; Bharath S; Purushottam M; Paul P; Sivakumar PT; Varghese M; Jain S
    Asian J Psychiatr; 2014 Dec; 12():58-62. PubMed ID: 25440562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.
    Amieva H; Mokri H; Le Goff M; Meillon C; Jacqmin-Gadda H; Foubert-Samier A; Orgogozo JM; Stern Y; Dartigues JF
    Brain; 2014 Apr; 137(Pt 4):1167-75. PubMed ID: 24578544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies.
    Bourdel-Marchasson I; Lapre E; Laksir H; Puget E
    Diabetes Metab; 2010 Jun; 36(3):173-81. PubMed ID: 20472485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetes mellitus and cognition: is there a link?].
    Barrou Z; Lemaire A; Boddaert J; Verny M
    Psychol Neuropsychiatr Vieil; 2008 Sep; 6(3):189-98. PubMed ID: 18786878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comprehensive management of dementia in old people with diabetes].
    Sakurai T
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():571-4. PubMed ID: 27266155
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.
    Raffaitin C; Gin H; Empana JP; Helmer C; Berr C; Tzourio C; Portet F; Dartigues JF; Alpérovitch A; Barberger-Gateau P
    Diabetes Care; 2009 Jan; 32(1):169-74. PubMed ID: 18945929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Dementia: Concept and Clinical Features in Diabetes-related Dementia].
    Hanyu H
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1901-6. PubMed ID: 30160895
    [No Abstract]   [Full Text] [Related]  

  • 28. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic disorder (diabetes mellitus, hypoglycemia, hyperglycemia, insulin resistance)].
    Fukushima T; Sasaki H
    Nihon Rinsho; 2004 Jan; 62 Suppl():379-83. PubMed ID: 15011390
    [No Abstract]   [Full Text] [Related]  

  • 32. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study.
    Anttila T; Helkala EL; Viitanen M; Kåreholt I; Fratiglioni L; Winblad B; Soininen H; Tuomilehto J; Nissinen A; Kivipelto M
    BMJ; 2004 Sep; 329(7465):539. PubMed ID: 15304383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
    Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
    Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.
    Bruce DG; Davis WA; Starkstein SE; Davis TM
    J Alzheimers Dis; 2014; 42 Suppl 3():S63-70. PubMed ID: 24840567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of Dementia-with Special Reference to Lifestyle and Vascular Risk Factors].
    Hanyu H
    Brain Nerve; 2018 Mar; 70(3):191-198. PubMed ID: 29519962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and cognitive impairment: how to evaluate the cognitive status?
    Pasquier F
    Diabetes Metab; 2010 Oct; 36 Suppl 3():S100-5. PubMed ID: 21211730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
    J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update on type 2 diabetes, vascular dementia and Alzheimer's disease.
    Exalto LG; Whitmer RA; Kappele LJ; Biessels GJ
    Exp Gerontol; 2012 Nov; 47(11):858-64. PubMed ID: 22884853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventive strategy for cognitive decline in elderly with diabetes mellitus].
    Sakurai T
    Nihon Rinsho; 2014 Apr; 72(4):692-6. PubMed ID: 24796099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.